The article addresses the skepticism that has arisen around funding sources for medical and food studies, particularly given the rise of social media influence. Some social media figures argue that pharmaceutical companies and food industries fund research to keep people ill for profit, urging the public to outright reject the findings of these studies. However, this viewpoint, despite its historical roots, overlooks significant changes in medical research practices over recent decades and fails to consider how science is evaluated today.

The article points out that there are indeed valid reasons for the loss of public trust in medical research, citing documented cases of commercial interests manipulating scientific research. Examples include past tobacco industry funding aimed at downplaying the risks of smoking and pharmaceutical studies that hid unfavorable results. These instances shocked public opinion and were pivotal in leading to stricter regulations and more rigorous oversight mechanisms in medical research.

Today, medical research is not solely funded by a single source. Governments and public entities primarily fund basic research and initial stages, such as understanding disease mechanisms and drug development phases. This shift aims to build greater transparency and trust in the research process, ensuring scientific integrity and reliability in medical findings, as opposed to relying solely on industry funding that may carry inherent conflicts of interest.